CHICAGO and ITASCA, Ill. – Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture innovation and part of Ajinomoto Group, today announced a collaboration to evaluate Ajinomoto Group’s StemFit™ stem cell culture products using […]
New funding will power foundational primary cell data generation to advance AI-driven discovery through the company’s full product launch. MONTREAL and BOSTON — DropGenie, a biotechnology company advancing next-generation gene editing workflows, today announced the closing of its Seed+ financing to support the launch of its first product. The round was led by Skeleton Key, […]
The total funding comprises US$1 million in angel investment and a US$4 million seed round. The seed financing round was led by Wavemaker Ventures, with participation by SEEDS, further supported by notable investors across the United States and Asia. The financing will support the continued expansion of ChemT’s AI and experimental infrastructure, which aims to […]
The collaboration will evaluate Ajinomoto Group’s stem cell culture products using Syntax Bio’s programmable stem cell differentiation platform to support improved regenerative medicine discovery, development, and manufacturing. CHICAGO & ITASCA, Ill. — Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a […]
Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x’s single cell and spatial platforms PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced a research collaboration with Cleveland Clinic, a nonprofit multispecialty academic medical center that integrates clinical care […]
Strengthens Board with experienced industry executive, specializing in strategic planning, organizational leadership and commercial execution Cambridge, UK – Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today announced the appointment of Bruce Eaton, PhD as Chairman of the Board, with immediate effect. The appointment aligns with the […]
GOTHENBURG, Sweden — MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation in life sciences, is showcasing its latest advancements in sequencing, automation and clinical genomics at the European Society of Human Genetics (ESHG) 2026 Conference in Gothenburg, Sweden. At Booth 352, MGI welcomes researchers, clinicians, laboratory […]
Hartwig to adopt Ultima Genomics’ UG200 sequencing system to accelerate implementation of whole-genome-based clinical genomics workflows on Solaris 2.0 technology Hartwig and Ultima to continue implementation and validation of ppmSeq, the only decentralizable whole-genome solution commercially available today for monitoring of minimal residual disease (MRD) with low single-digit part-per-million sensitivity AMSTERDAM and FREMONT, Calif. — […]
Updated kits deliver improved sensitivity and receptor recovery for single cell immune repertoire profiling at unprecedented scale SEATTLE — Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today launched the next generation of its Evercode™ TCR and Evercode™ BCR kits, shipping to customers worldwide. The updated kits deliver a streamlined workflow, better whole transcriptome […]
CellVoyant and Axol Bioscience announce strategic collaboration to advance AI-guided predictive imaging assays for cardiomyocyte manufacturing Collaboration combines CellVoyant AI-powered FateView™ platform with Axol Bioscience induced pluripotent stem cell (iPSC) expertise to enable predictive, non-destructive assessment of cardiomyocyte differentiation processes, enabling the generation of highly pure cell populations at scale. BRISTOL, UK and EDINBURGH, UK […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
